Steris is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 5960 heisley road, mentor, oh. Webfind the latest steris plc (ste) stock analysis from seeking alpha’s top analysts: Exclusive research and insights from bulls and bears. Websteris plc has seen its earnings per share (eps) increase by 6. 1% a year over the past three years. It achieved revenue growth of 13% over the last year. Websteris’s board of directors has unanimously appointed dan carestio, currently chief operating officer (coo), to the board of directors as of january 29,. Webas a premier medical device company, steris plc continues to demonstrate financial resilience and strategic acumen, with its latest sec filing underscoring a robust. Websteris plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: Webin the fourth quarter of fiscal 2021, steris eliminated the use of lifo for inventory accounting, which impacted our quarterly profit measures for fiscal 2021. Websteris announces financial results for fiscal 2025 first quarter. Steris raises dividend to $0. 57 per share. Steris is a leading provider of infection. Websteris has an overall rating of 3. 6 out of 5, based on over 1,085 reviews left anonymously by employees. 67% of employees would recommend working at.
